Pulmonary Drug Delivery Systems Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025
Report Description
Global Pulmonary Drug Delivery SystemsMarket is expected to grow at CAGR of 6.2% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Pulmonary Drug Delivery Systems Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market.
The major key players of the market are as follows:
KEY PLAYERS
3M PHARMACEUTICALS, INC.
ASTRAZENECA PLC
BOEHRINGER INGELHEIM GMBH
CIPLA, INC.
DR. REDDY'S LABORATORIES LTD.
GLAXOSMITHKLINE PLC
KONINKLIJKE PHILIPS N.V. (RESPIRONICS, INC.)
LUPIN, LIMITED
MYLAN N.V.
NOVARTIS AG
OMRON CORPORATION
PFIZER, INC.
PULMATRIX, INC.
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
VECTURA GROUP PLC
Scope of the Market
Disease Area Market
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Other Diseases
Geography Market
North America
Europe
Asia Pacific
Rest of the World (RoW)
Payment Options